FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/30/2023
Back to search
Official data from USPTO
SEEGENE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
05/30/2023
Trademark type
Word
Nice classes
42, 44
Filing date
07/06/2021
Registration date
01/31/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/31/2023
Last transaction
01/31/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
KR
Examiner
KEELEY, ALISON
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SEEGENE, INC.
Representatives
Max Vern Amster, Rothstein & Ebenstein LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development in the field of special testing using genetic engineering; biological servicestesting and analysis of biological samples in research laboratories; research and development of DNA chips; structural and functional analysis of genomes; biotechnological research; advisory services relating to biotechnological research; biological research; biochemical analysis; biochemical research; research in the field of gene analysis; genetic research; chemical analysis; research in the field of chemistry; chemical research and analysis; chemical research; research and development of vaccines and medicines; crude drugs research; research on adult diseases; bacteriological research; scientific research for medical purposes in the field of cancerous diseases; research relating to medicines; pharmaceutical products evaluation; consultancy pertaining to pharmacology; testing of pharmaceuticals; pharmaceutical research; medical research; medical science research in the field of clinical pathology and special examination; scientific research in the nature of conducting clinical trials for others; medical research and technical diagnostic testing services for evaluating clinical trial progress; medical research laboratory services for predicting disease; medical laboratory servicespreparation and analysis of human body tissue and fluid samplesproviding reports respecting the same; research and development of infectious disease diagnosis products; research and development agency of infectious disease diagnosis products; research and development of bacterial and virus test products; research and development agency of bacterial and virus test products; research and development of genetic disease diagnosis products; research and development agency of genetic disease diagnosis products; research and development of blood analysis; research and development agency of blood analysis; research and development agency of cell test products for medical researchtreatmentdiagnosis; research and development of cell test products for medical researchtreatmentdiagnosis; research and development of body fluid and tissue sample analysis products for medical researchtreatmentdiagnosis; research and development agency of body fluid and tissue sample analysis products for medical researchtreatmentdiagnosis
Class 44
Pharmaceutical advice; pharmacy advice in the field of preparation of prescriptions in pharmacies; providing medical information relating to diagnosticprophylactic and therapeutic properties of medical products; providing medical information relating to diagnosticprophylactic and therapeutic properties of medical products via the Internet; telemedicine services; medical services; medical information services provided via the Internet; medical and pharmaceutical consultation; medical testing servicesmedical diagnostic testing; medical testing for diagnostic or treatment purposes; medical cancer testing for diagnostic or treatment purposes; genetic testing for medical purposes; healthcare services through the Internet; consulting services in the field of health management in the nature of managing health conditions through the internet; medical clinical pathology examination; health checkup and information services related thereto; medical clinical test in the nature of diagnostic testing and genetic testing for treatment purposes and information services related thereto; providing collected and managed medical information and personal health information; medical screening and examining services for disease prevention of cancerinfectious disease by pathogens and genetic disease by mutation; medical screening and examining services for disease prevention of cancerinfectious disease by pathogens and genetic disease by mutation to improve health culture; healthcare; health counselling; physical examination services; hospital servicesnot including dentistry services; medical clinic servicesnot including dentistry services; telemedicine servicesnot including dentistry services; rental of medical and health care equipment; medical assistance services; medical consultation servicesnot including dentistry services; medical equipment rental; providing health information servicesnot including dentistry services; health center services; performing diagnosis of diseases; medical and diagnostic servicesidentifying hereditary risk factors; medical and medical diagnostic services for disease prevention; medical and diagnostic servicesdiagnosing in the nature of in vitro diagnostic services for medical purposes; medical analysis services relating to the treatment of personsanalysis of human bodily fluid and tissue samples for diagnostic and treatment services provided by a medical laboratory
Publications
History of USPTO decisions and trademark events.
26 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/04/2023
FIMP
FINAL DISPOSITION PROCESSED
05/04/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/30/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/31/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/31/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/15/2022
PUBO
PUBLISHED FOR OPPOSITION
11/15/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/26/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/10/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
10/10/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/10/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
10/10/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/10/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/10/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/09/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/09/2022
RFNT
REFUSAL PROCESSED BY IB
06/06/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/16/2022
RFRR
REFUSAL PROCESSED BY MPU
05/16/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/01/2022
CNRT
NON-FINAL ACTION WRITTEN
03/31/2022
DOCK
ASSIGNED TO EXAMINER
03/25/2022
MAFR
APPLICATION FILING RECEIPT MAILED
10/30/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/26/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/22/2021
Continuous trademark protection
Get notified about every new filing that threatens SEEGENE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.